Clinical Trial

Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block on Postoperative Pain After Septoplasty

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are: Will the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block. Participants will: Read the information Participants have been given about the sphenopalatine ganglion block. In case of any side effects, please contact participant's doctor.
Trial Details
NCT Number NCT06695624
Lead Sponsor Umraniye Education and Research Hospital
Conditions Postoperative Pain
Enrollment 50 participants
Start Date 2024-11
Primary Completion 2025-01 (estimated)
Study Completion 2025-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-19